Endovascular treatment improves cognition after stroke: A secondary analysis of REVASCAT trial.

ABSTRACT:

Objective

To investigate the effect of endovascular treatment on cognitive function as a prespecified secondary analysis of the REVASCAT (Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours) trial.

Methods

REVASCAT randomized 206 patients with anterior circulation proximal arterial occlusion stroke to Solitaire thrombectomy or best medical treatment alone. Patients with established dementia were excluded from enrollment. Cognitive function was assessed in person with Trail Making Test (TMT) Parts A and B at 3 months and 1 year after randomization by an investigator masked to treatment allocation. Test completion within 5 minutes, time of completion (seconds), and number of errors were recorded.

Res

SUBMITTER: Lopez-Cancio E 

PROVIDER: S-EPMC5272792 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature